14 results
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
15 Apr 24
Report of Foreign Private Issuer
4:01pm
oder der Geschäftsleitung kann mehr als fünf solche Mandate wahrnehmen.
Mandates in associations, charitable organizations, foundations, trusts
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
14 Mar 24
Report of Foreign Private Issuer
9:00am
oder der Geschäftsleitung kann mehr als fünf solche Mandate wahrnehmen.
Mandates in associations, charitable organizations, foundations, trusts
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
13 Dec 22
Report of Foreign Private Issuer
7:31pm
Mandate wahrnehmen.
b) Mandates in associations, charitable organizations, foundations, trusts and employee welfare foundation. No member
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
28 Oct 22
Report of Foreign Private Issuer
4:00pm
Mandate wahrnehmen.
b) Mandates in associations, charitable organizations, foundations, trusts and employee welfare foundation. No member
6-K
EX-3.1
NLSP
NLS Pharmaceutics Ltd
7 Oct 22
Report of Foreign Private Issuer
4:01pm
wahrnehmen.
b) Mandates in associations, charitable organizations, foundations, trusts and employee welfare foundation. No member of the board of directors
6-K
EX-3.1
782v8u ztmg
16 Sep 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-3.1
s0i 5grmy0x4sdvgc44
3 Jun 22
Report of Foreign Private Issuer
5:00pm
6-K
EX-3.1
7w1kv 5gw
14 Dec 21
Report of Foreign Private Issuer
4:59pm
6-K
EX-3.1
z510f0pkw6xip mhe
23 Nov 21
Report of Foreign Private Issuer
7:11am
6-K
EX-3.1
gu3vz9i
26 Oct 21
Report of Foreign Private Issuer
4:00pm
6-K
EX-3.1
ilmjc dv29nc35
9 Feb 21
Report of Foreign Private Issuer
12:00am
6-K
EX-3.2
w538qvlz xnjkf3siq
9 Feb 21
Report of Foreign Private Issuer
12:00am
6-K
EX-3.1
ilqfog 9v2l84h776uuj
2 Feb 21
NLS Pharmaceutics Ltd. Announces Closing of $20.0 Million Initial Public Offering
5:29pm
F-1/A
EX-3.1
amjic5ms9mujt4llu
16 Oct 20
Registration statement (foreign) (amended)
9:59pm
- Prev
- 1
- Next